Who We Are
Biovance Solutions is a science-driven life sciences services organization supporting pharmaceutical and biotechnology companies across drug development, regulatory affairs, pharmacovigilance and medical writing.
Our approach is built on deep scientific expertise, global regulatory understanding, and a sponsor-centric mindset—ensuring every engagement delivers measurable value and dependable outcomes.
Vision
To be the trusted development partner for innovators, optimizing timelines, cost, and risk across the product development lifecycle.
Mission
To accelerate safe patient access to new therapies by delivering regulatory-ready science and dependable safety surveillance—without compromising quality, compliance, or integrity.
Our Leadership Team
Founder & Managing Director
Punam Kumari is a distinguished life sciences professional with over 20 years of experience in global drug development, regulatory science, and safety operations. She holds a Bachelor’s degree in Pharmacy from the Manipal Academy of Higher Education (MAHE) and a Postgraduate degree in Pharmacology and Drug Discovery from Coventry University, UK, where she developed a strong foundation in translational science and modern drug development. Punam has contributed to high-impact programs across the pharmaceutical and biotechnology landscape, including work with leading global organizations such as GlaxoSmithKline (GSK), where she gained first-hand exposure to advanced clinical and pharmacovigilance operations. She has also held strategic roles at Tata Consultancy Services (TCS), one of the world’s largest life sciences service providers, strengthening her expertise in large-scale global delivery models. An ISO-certified auditor, Punam brings a strong focus on quality, compliance, and operational excellence to every initiative she leads. She is also a passionate educator, having served as a Guest Lecturer at universities in the UK and India, and a recognized thought leader who has spoken at international conferences on topics including drug safety, regulatory science, and clinical development. Known for her strategic vision and people-centric leadership style, Punam is widely respected for her ability to navigate complex scientific and operational challenges while inspiring teams to deliver high-quality, impactful results.
Head of Business Development
Garima Agarwal is a seasoned pharmaceutical professional with over 15 years of cross-functional experience spanning toxicology, pre-clinical research, medical affairs, pharmaceutical marketing, and industry–academia collaborations. With a strong foundation in pharmaceutical sciences and toxicology, complemented by extensive exposure to market intelligence and business development, she brings a rare blend of scientific depth and strategic marketing insight to the life sciences domain. She holds a bachelor’s degree in pharmacy from Sri Ramachandra Medical College & Research Institute (SRMC & RI), Chennai and a Post-graduate degree in Pharmaceutical Biotechnology from SRM University, Chennai. She is currently pursuing her PhD in Pharmaceutical Sciences from DIT University, Dehradun. She currently serves as Head of Business Development at Biovance Solutions, where she leads strategic growth initiatives, industry partnerships, and client acquisition for Pharmacovigilance, Regulatory, Toxicology and Pre-clinical service offerings. In parallel, Garima is an Associate Professor in the Department of Pharmaceutical Technology at Meerut Institute of Engineering & Technology (MIET), where she has played a pivotal role in building industry-aligned pre-clinical and toxicology infrastructure. A key contributor to institutional capacity building, she has conceptualized and established multiple Centers of Excellence, including a Center for Pre-Clinical Research, Center for Cruelty-Free Testing, and a Neurodegenerative Research Centre using zebrafish models, ensuring regulatory alignment and scientific rigor. In parallel, Garima brings significant pharmaceutical and healthcare marketing experience, having held leadership roles in IMS Health (IQVIA), digital marketing agencies, and consulting organizations. At IMS Health, she worked on market assessment, competitive intelligence, epidemiology, KOL mapping, and therapy-area analytics across diabetes, transplant medicine, osteoporosis, and oncology-related domains. Her subsequent roles as General Manager and Marketing & Operations Head further strengthened her expertise in strategic marketing, client engagement, proposal development, brand positioning, and business development for healthcare and life-sciences offerings. Her ability to seamlessly bridge science, strategy, and commercialization enables her to translate complex toxicology and research outputs into compelling value propositions for stakeholders. With published research in peer-reviewed journals and a consistent focus on quality, compliance, and impact, Garima Agarwal continues to contribute meaningfully to the evolving pharmaceutical and life-sciences ecosystem.
Head of Operations & Quality
Dr. Alok Sharma is a pharmaceutical professional with more than 21 years of experience across drug discovery, clinical research, pharmacovigilance, quality systems, and industry academia collaboration. He has a strong background in pharmaceutical operations and quality, along with hands-on experience in R&D, analytical sciences, and pharmaceutical commercialization. He completed his Doctorate at Manipal University in collaboration with NBRI (CSIR) and pursued postdoctoral research at the Institute of Personalized Medicine (Med-X Research Center), Shanghai Jiao Tong University, China. Dr. Sharma is currently working as Head Operations & Quality at Biovance Solutions, where he is responsible for the development, implementation, and oversight of Pharmacovigilance Quality Management Systems. He played a key role in establishing the Drug Research and Biotech Incubation Centre (DRBIC) at MIET and has led several technology transfer initiatives. His professional experience covers formulation development, scale-up, and process validation. He has played an active role in signing more than seven MoUs with medical colleges, hospitals, and pharmaceutical companies, fostering collaboration in research, technology transfer, and training programs. During his academic career, Dr. Sharma has published over 50 peer-reviewed research papers, supervised postgraduate dissertations, and taught undergraduate students. He is a life member of several professional organizations, including the Indian Pharmaceutical Association (IPA), APTI, and Pharmacovigilance Society of India.
Head of Pharmacovigilance and Regulatory Technology
Dr. Shipra Sehgal is a seasoned Dental Surgeon and Pharmacovigilance leader with over 14 years of global experience across India and the UK, spanning clinical practice, large-scale drug safety operations, and PV & regulatory technology transformation. She has partnered with leading CROs including Parexel International, Freyr Solutions, and Quantum Solutions India, supporting top-tier pharmaceutical and biotechnology clients across multiple geographies. In recent years, she has led technology-driven initiatives, in health care, automation of case processing workflows, and digital optimisation of regulatory compliance processes. Her expertise encompasses end-to-end ICSR management, literature surveillance, and audit readiness, strengthened by her credentials as a Certified Lead Auditor, enabling her to drive inspection readiness, compliance governance, and continuous quality improvement. She also has strong capabilities in process standardisation, and data-led operational governance. With formal training in PMP and Six Sigma, Dr. Shipra brings a strategic, scalable approach to building globally aligned PV and regulatory technology functions, positioning her strongly for senior leadership roles within global CRO environments.